Delivery Order SPE2DB22D1017-SPE2DB24FF2KH
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MULTAQ 400 MG TABLET 60S pharmaceuticals. The $17,601.39 contract has an ultimate completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,558,085,095 MULTAQ 400 MG TABLET 60S. The $111,931.36 contract has an August 15, 2022 completion date and was awarded on August 12, 2022. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,033.84 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563250118 MULTAQ 400 MG TABLET 60S. This delivery order has a completion date of January 8, 2024 and was awarded on January 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which falls under a larger indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MULTAQ 400 MG TABLET 60S. The $2,931.96 contract has an ultimate completion date of April 10, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with a potential value...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $16,793.26 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of MULTAQ 400 MG TABLET 60S. This contract has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product MULTAQ 400 MG Tablet 60s. The $14,014.66 contract has a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $42,929.06 contract is for the supply of the prescription medication MULTAQ 400 MG TABLET 60S. The delivery order has an ultimate completion date of April 5, 2024. AmerisourceBergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation....
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $4,197.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of MULTAQ 400 MG TABLET 60S, a specialty pharmaceutical product. This delivery order award is under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $9,835.70 contract is for the delivery of MULTAQ 400 MG TABLET 60S pharmaceutical products to be completed by February 15, 2024. This order is placed under Amerisourcebergen's existing $999,999,999.00 indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $1,907.60 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, for the supply of MULTAQ 400 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF2KHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,850.30 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563556699 MULTAQ 400 MG TABLET 60S. The firm fixed price contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor and provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through multiple contract vehicles. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 2/5/24 |